BIOFARM INC
NT 10-Q, 1999-03-12
HAZARDOUS WASTE MANAGEMENT
Previous: OMEGA HEALTHCARE INVESTORS INC, DEF 14A, 1999-03-12
Next: FLEX PARTNERS/, N-30D, 1999-03-12






                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 12b-25

                           NOTIFICATION OF LATE FILING

(Check one)
 __ Form 10-K and Form 10-KSB  __ Form 20-F __ Form 11-K   _X_ Form 10-Q and 
    Form 10-QSB __ Form N-SAR    

        For Period Ended January 31, 1999                    
        __ Transition Report on Form 10-K and Form 10-KSB    
        __ Transition Report on Form 20-F                    
        __ Transition Report on Form 11-K                    
        __ Transition Report on Form 10-Q and Form 10-QSB    
        __ Transition Report on Form N-SAR                   
        For the Transition Period Ended:_____________        

Read Instructions (on back page) Before Preparing Form, Please Print or Type.

Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify
the item(s) to which the notification relates:

PART I--REGISTRANT INFORMATION

Full Name of Registrant: Biofarm, Inc.                          
                         --------------------------------------
Former Name of Registrant: Global Spill Management, Inc. 
                           -------------------------------------
Address of Principal Executive Office (Street and Number):

1244 Main Street, Linfield, Pennsylvania  19468
- -----------------------------------------------


<PAGE>


PART II--RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25b, the following should
be completed. (Check box if appropriate): | X |
                                           ---
     (a)  The reasons described in reasonable detail in Part III of this form
          could not be eliminated without unreasonable effort or expenses;
     (b)  The subject annual report, semi-annual report, transition report on
          Forms 10-K, 10-KSB, Form 20-F, 11-K, Form N-SAR, or portion thereof,
          will be filed on or before the fifteenth calendar day following the
          prescribed due date; or the subject quarterly report or transition
          report on Forms 10-Q, 10-QSB, or portion thereof will be filed on or
          before the fifth calendar day following the prescribed due date; and
     (c)  The accountant's statement or other exhibit required by Rule 12b-25(c)
          has been attached if applicable.

PART III--NARRATIVE

State below in reasonable detail the reasons why the Forms 10-K, 10-KSB, 20-F,
11-K, 10-Q,10-QSB, N-SAR, or the transition report or portion thereof, could not
be filed within the prescribed time period. (Attach Extra Sheets if Needed)

     The Company has not been able to finalize the financial statements for the
Company's Quarterly Report on Form 10-QSB by March 17, 1999, the required filing
date, without unreasonable effort.

PART IV--OTHER INFORMATION

(1)  Name and telephone number of person to contact in regard to this
     notification

Keith D. Beekmeyer              (610)             495-8413     
- ------------------           -----------     ------------------
    (Name)                    (Area Code)     (Telephone Number)

(2)  Have all other periodic reports required under Section 13 or 15(d) of the
     Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
     of 1940 during the preceding 12 months (or for such shorter period that the
     registrant was required to file such reports) been filed? If answer is no,
     identify report(s). X Yes No
                        --     --

(3)  Is it anticipated that any significant change in results of operations from
     the corresponding period for the last fiscal year will be reflected by the
     earnings statements to be included in the subject report or portion
     thereof? Yes X No
                 --   --
     If so, attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a reasonable
estimate of the results cannot be made.


<PAGE>


                                  Biofarm, Inc.
                           --------------------------
                  (Name of Registrant as Specified In Charter)

has caused this notification to be signed on its behalf by the undersigned
hereto duly authorized

Dated: March  11, 1999                   BIOFARM, INC.


                                         By: /s/ Keith D. Beekmeyer       
                                             -----------------------------
                                             Keith D. Beekmeyer, President
                                             and Chairman of the Board


INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.

                                    ATTENTION

     Intention misstatements or omissions of fact constitute Federal Criminal
Violations (See 18 U.S.C. 1001).

                              GENERAL INSTRUCTIONS

1.   This form is required by Rule 12b-25 (17 CFR 240.12b-25 of the General
     Rules and Regulations under the Securities Exchange Act of 1934.

2.   One signed original and four conformed copies of this form and amendments
     thereto must be completed and filed with the Securities and Exchange
     Commission, Washington, D.C. 20549, in accordance with Rule 0-3 of the
     General Rules and Regulations under the Act. The information contained in
     or filed with the form will be made a matter of public record in the
     Commission files.

3.   A manually signed copy of the form and amendments thereto shall be filed
     with each national securities exchange on which any class of securities of
     the registrant is registered.

4.   Amendments to the notifications must also be filed on form 12b-25 but need
     not restate information that has been correctly furnished. The form shall
     be clearly identified as an amendment notification.






© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission